Navigation Links
Cerulean Pharma to Present Data on CRLX101's HIF-1a Inhibition at the American Association for Cancer Research Annual Meeting
Date:4/4/2013

X101 in combination with anti-angiogenic agents are very impressive. I am excited that we can bring this combination hypothesis into the clinic, and I am encouraged by the results of this trial to date," said Dr. Keefe. "CRLX101's favorable safety profile is encouraging, and its ability to provide durable inhibition of HIF-1a could increase the benefit that anti-angiogenic agents provide to patients."

In addition, Cerulean scientists will participate in the following sessions at AACR:

  • CRLX101, a nanopharmaceutical in phase 2 clinical trials, is synergistic with antiangiogenic treatment through HIF-1a inhibition in an ovarian cancer xenograft model (April 7, 1:00 – 5:00 pm): Douglas Lazarus , director of biology at Cerulean, will present a poster on the improved efficacy of antiangiogenic drugs when combined with CRLX101.
  • Nanotechnology Approaches to the Treatment of Cancer (April 7, 1:00 – 3:00 pm): Dr. Scott D. Eliasof , vice president of research at Cerulean, will participate in a panel discussion led by Mark Davis of the California Institute of Technology on the advantages of using nanoparticles such as CRLX101 for the treatment of cancer, including how nanotechnology enabled the creation of the first clinically relevant HIF-1a inhibitor.

About CRLX101

CRLX101 is an investigational anti-cancer agent that is a dual inhibitor of topoisomerase 1 and hypoxia-inducible factor-1α. CRLX101 is a dynamically tumor-targeted nanopharmaceutical designed to concentrate in tumors and release its payload, camptothecin, over an extended period of time, prolonging drug exposure at the site of action. Anti-tumor activity has been observed across a wide range of cancers in animal models and in seven clinical trials. CRLX101 is currently in Phase 2 clinical development. More informatio
'/>"/>

SOURCE Cerulean Pharma Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Cerulean Pharmas Lead Candidate Selected as a "Top 10 Oncology Project to Watch"
2. Cerulean Announces First Patient Dosed in Phase 2 Study of CRLX101 in Ovarian Cancer
3. Merrimack Pharmaceuticals Announces Top-Line Results From A Single Arm Phase 2 Advanced Lung Cancer Study In Patients With Resistance To An Anti-EGFR Tyrosine Kinase Inhibitor
4. Valeant Pharmaceuticals Provides Update to Recent Event
5. X-BODY Announces Multi-Million Dollar Development Alliance With Jiangsu Hengrui Medicine Co., Ltd., A Leading Pharmaceutical Company In China, To Develop Novel Therapeutic Antibodies For AMD
6. Oramed Pharmaceuticals Granted Japanese Patent for its Core Technology in Oral Delivery of Proteins
7. Valeant Pharmaceuticals And Obagi Medical Products Agree On An Increased Offer Price Of $24.00 Per Share In Cash
8. DFH Pharma, USA Partners with Hetero Group, INDIA to Develop 2nd Generation HIV Maturation Inhibitor Drugs
9. Collegium Pharmaceutical Names Douglas Carlson to Vice President of Business Development
10. Kentucky Health Cooperative To Partner With ProCare Rx For Pharmacy Benefit Management
11. Simcere Pharmaceutical Group Announces its Special Committees Engagement of Financial Advisor
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/24/2014)... LONDON , December 24, 2014 /PRNewswire/ ... expected to grow at an average rate of 8.1%. ... and volume. Hip, knee and spine surgeries are the ... emerging economies they have a lower penetration. Increased number ... use of composites. Non-metallic orthopedic devices have gained popularity ...
(Date:12/24/2014)... ResMed (NYSE: RMD ) today announced its victory ... manufacturer BMC Medical Co., Ltd. The International ... infringe ResMed,s patents, and entered an order prohibiting BMC from ... United States : , iVolve nasal mask ... pillows mask , iVolve full face mask ...
(Date:12/24/2014)... 2014  Lockton Dunning Benefits, the ... the addition of Vice President Kim Foerster ... Pharmacy Consulting team, Excelsior Solutions. ... to the position.  Most recently, she worked as ... Specialty Pharmacy, where she has held various managerial ...
Breaking Medicine Technology:Use of Composites in Orthopedic Industry to Reach $596 Million by 2020 2Use of Composites in Orthopedic Industry to Reach $596 Million by 2020 3ResMed Wins Patent Infringement Lawsuit Against Chinese Manufacturer BMC Medical 2Kim Foerster Joins Lockton Companies 2
... Jan. 4, 2012 "My philosophy in treating patients is ... fully achieve their goals," mentions Robert Paresi, MD, board ... Medical Center in Lake Geneva, Wisconsin and Mercy Regional ... recently joined Mercy Health System with the intent to provide ...
...   Kedem Pharmaceuticals Inc. (OTCBB: KDMP), a specialty ... pleased to announce that it has signed a contract ... Corealis Pharma, Inc. for the production of the phase ... therapeutic drug. The KDM-1102 drug is a new sublingual ...
Cached Medicine Technology:Fulfill New Year Resolutions with Cosmetic Surgery 2Kedem Pharmaceuticals Engages a FDA Compliant Contract Formulation Development Company for the Production of KDM-1102 Clinical Materials 2Kedem Pharmaceuticals Engages a FDA Compliant Contract Formulation Development Company for the Production of KDM-1102 Clinical Materials 3
(Date:12/25/2014)... FL (PRWEB) December 25, 2014 When head ... find themselves in a frenzy to get rid of it ... But families in Coral Gables now have the solution right ... second salon clinic location, Lice Troopers provides full spectrum head ... the Coral Gable area, including Sunset, Key Biscayne, Brickell, Coconut ...
(Date:12/25/2014)... 25, 2014 (HealthDay News) -- The risk of burns ... so you need to be extra cautious, an expert ... see a significant increase in patients coming in with ... Suffolk County Volunteer Firefighters Burn Center of Stony Brook ... be full of joy, but if not careful, could ...
(Date:12/25/2014)... Dennis Thompson HealthDay Reporter ... be closing in on a "fountain of youth" drug that ... of older adults, a new study suggests. Seniors received ... drug that targets a genetic signaling pathway linked to aging ... The experimental medication, a version of the ...
(Date:12/25/2014)... “ SmileStix ” was featured on NewsWatch as part of ... applications on the iOS, Android, and Windows markets. Andrew Tropeano, ... app review and shared with viewers how this is an ... saying goes, “A picture says a thousand words.” It’s true. ... single image, because each picture holds a unique and special ...
(Date:12/25/2014)... Rosa, CA (PRWEB) December 25, 2014 ... department visits and 2 million hospital admissions across the ... and Prevention ). The CDC’s National Hospital Ambulatory ... departments through a survey conducted in 2010. They estimated ... department visits that resulted in a primary diagnosis of ...
Breaking Medicine News(10 mins):Health News:Coral Gables Florida Gets Ready to Be Lice-Free with Lice Troopers 2Health News:Don't Let Burns Mar Your Holidays 2Health News:Researchers Take 'First Baby Step' Toward Anti-Aging Drug 2Health News:Researchers Take 'First Baby Step' Toward Anti-Aging Drug 3Health News:An Application to Create Custom Stickers was Featured on NewsWatch Television on December 19, 2014 2Health News:Every Year Four Million Emergency Department Visits Result from Accidents Involving Bone Trauma 2Health News:Every Year Four Million Emergency Department Visits Result from Accidents Involving Bone Trauma 3Health News:Every Year Four Million Emergency Department Visits Result from Accidents Involving Bone Trauma 4
... Genaera,Corporation (Nasdaq: GENR ) today announced that ... of the Company,s common stock,has closed below the minimum ... the last 30 consecutive trading days., NASDAQ also ... it has,suspended for a three-month period the enforcement of ...
... Michael Chiarello and The American Association of,Orthodontists team up to provide ... ... recipes, ST. LOUIS, Oct. 21 If ... be a sweet experience. Celebrity chef,and author Michael Chiarello, of Food ...
... 21 /Xinhua-PRNewswire/ -- Mindray Medical,International Limited (NYSE: ... medical devices worldwide announced today that it will ... from October,29 to November 1., Mindray will ... core product,segments: patient monitoring & life support products, ...
... SectorWatch.biz announces the,availability of MarketStats for health ... today. MarketStats offers a perspective on the,aforementioned equities ... blogs and opinions., Investors can view MarketStats ... FiSpace.net, a dynamic social networking site for,investors., ...
... consumer wants service, convenience, and quality from their physician, all while saving ... is a service today,s consumer demands. Physicians can now meet this ... ... OH (PRWEB) October 21, 2008 -- Three out of four Americans would ...
... dentistry in Mexico at fraction of the US cost. Andy got ... in one sitting. Overseas Dentistry, including dental implants abroad cost ... ... Burbank, CA (PRWEB) October 21, 2008 -- Andy Gobienko was eating a ...
Cached Medicine News:Health News:Genaera Receives Non-Compliance Notice From NASDAQ 2Health News:Good News for Trick-or-Treaters With Braces: Renowned Chef to the Rescue With Braces-Friendly Treats 2Health News:Good News for Trick-or-Treaters With Braces: Renowned Chef to the Rescue With Braces-Friendly Treats 3Health News:Good News for Trick-or-Treaters With Braces: Renowned Chef to the Rescue With Braces-Friendly Treats 4Health News:Mindray Medical to Exhibit New Products at 60th China International Medical Equipment Fair 2Health News:SectorWatch.biz Issues MarketStats on NWCI, ERES, STJ, MDT, BSX, and CSCX 2Health News:Physician Dispensing Wins In A Landslide Majority Of Enhancing Patient Experience 2Health News:Physician Dispensing Wins In A Landslide Majority Of Enhancing Patient Experience 3Health News:Dental Crown in Mexico -- Medical Tourism Corporation Assists US Teen with Huge Savings 2Health News:Dental Crown in Mexico -- Medical Tourism Corporation Assists US Teen with Huge Savings 3
The cementless acetabular shells form part of the Mallory head range of femoral and acetabular implants....
The cementless BiHAPro cup combines proven concepts with the latest innovations in cementless THR....
Trident Hemispherical Acetabular Shells are a true hemispherical shape designed to achieve press-fit fixation by under-reaming the acetabulum....
The Secur-Fit cups incorporate enhancements derived from years of clinical, radiographic, and implant retrieval observations....
Medicine Products: